Impact of Different Lung Isolation Devices on Pharyngolaryngeal Injuries After Pulmonary Resection
PLIAP
Impact of Laryngeal Mask Combined With Visual Bronchial Blocker on Pharyngolaryngeal Injuries After Pulmonary Resection
1 other identifier
interventional
270
1 country
3
Brief Summary
The goal of this clinical trial is to assess the impact of laryngeal mask combined with visual bronchial blocker on pharyngolaryngeal injury after pulmonary resection in patients with pulmonary nodules. The main question it aims to answer is: the incidence of postoperative pharyngolaryngeal injury within 24h : sore throat and hoarseness ? Researchers will compare the visual bronchial blocker group (VBB) with the double-lumen endotracheal tube group (DLT) to see if the visual bronchial blocker group can minimize laryngopharyngeal injury after pulmonary resection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2025
CompletedFirst Posted
Study publicly available on registry
August 12, 2025
CompletedStudy Start
First participant enrolled
August 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedJanuary 15, 2026
January 1, 2026
2 months
July 16, 2025
January 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of pharyngolaryngeal injuries within postoperative 24 hours
sore throat and hoarseness
within postoperative 24 hours
Secondary Outcomes (10)
Incidence of pharyngolaryngeal injuries within postoperative an hour
within postoperative an hour
Incidence of pharyngolaryngeal injuries within postoperative 48 hours
within postoperative 48 hours
Intraoperative device displacement
during the operation
Intraoperative hypoxemia
during the operation
Lung collapse quality
at 5, 10, and 20 minute during single-lung ventilation
- +5 more secondary outcomes
Study Arms (2)
visual bronchial blocker group(VBB)
EXPERIMENTALLaryngeal Mask Airway(LMA) size selection based on patient weight (≥70kg: size 5, 50-70kg: size 4, \<50kg: size 3);Standard LMA insertion technique in supine position;Visual bronchial blocker inserted through LMA central channel;Blocker advancement under direct vision to identify carina
double-lumen endotracheal tube group(DLT)
ACTIVE COMPARATORSize selection based on patient gender and height: Male: \>180cm (37F), 160-180cm (35F), \<160cm (32-35F);Female: \>160cm (35F), \<155cm (32F), 155-160cm (individualized);Standard laryngoscopy and DLT insertion;Fiberoptic bronchoscopy confirmation of positioning;Tracheal cuff pressure 25 cmH2O, bronchial cuff pressure 30 cmH2O
Interventions
lung isolation with visual bronchial blocker
lung isolation with double-lumen endotracheal tube
Eligibility Criteria
You may qualify if:
- Age ≥18 years
- Scheduled for elective VATS pulmonary resection under general anesthesia
- American Society of Anesthesiologists (ASA) physical status I-III
- Body mass index (BMI) 18.5-30.0 kg/m²
- Written informed consent
You may not qualify if:
- Anticipated difficult airway (Mallampati class IV, previous difficult intubation, airway abnormalities)
- Gastroesophageal reflux disease or gastric retention
- Active pulmonary infection or bleeding
- Severe pulmonary dysfunction (FEV1 \<50% predicted)
- Previous lung surgery or bilateral lung surgery
- Cognitive impairment affecting outcome assessment
- Chronic throat pain or voice abnormalities within 24 hours preoperatively
- Abnormal right upper lobe bronchial anatomy on preoperative CT for right-sided procedures
- Any condition deemed unsuitable for study participation by anesthesiologist or surgeon
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Tingting Lilead
- Charta Foundationcollaborator
Study Sites (3)
Shanghai Chest Hospital
Shanghai, 200030, China
Shanghai Pulmonary Hospital
Shanghai, 200433, China
The Second Military Medical University Changhai Hospital
Shanghai, 200433, China
Related Publications (1)
Zhang Y, Li T, Wei J, Bao R, Lv X, Wang JF, Wu J. Laryngeal mask airway combined with visual bronchial blocker versus double-lumen tube for lung isolation in video-assisted thoracoscopic surgery: a protocol for a multicentre randomised controlled trial. BMJ Open. 2025 Dec 30;15(12):e110539. doi: 10.1136/bmjopen-2025-110539.
PMID: 41469076DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jingxiang Wu
Shanghai Chest Hospital
- PRINCIPAL INVESTIGATOR
Tingting Li
Shanghai Chest Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
July 16, 2025
First Posted
August 12, 2025
Study Start
August 18, 2025
Primary Completion
October 31, 2025
Study Completion
November 30, 2025
Last Updated
January 15, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share